Significance of serum CXCL10/IP-10 level in type 1 diabetes

Journal of Autoimmunity

Volumn 26, Issue 1, 2006, Pages 66-71

  Shigihara, Toshikatsu ^a   Oikawa, Yoichi ^a   Kanazawa, Yasuhiko ^a   Okubo, Yoshiaki ^a   Narumi, Shosaku ^b   Saruta, Takao ^a   Shimada, Akira ^a  

^a KEIO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chemokine; CXCL10 IP 10; Non obese diabetic mouse; Type 1 diabetes mellitus

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

ANIMALS; CHEMOKINES, CXC; DIABETES MELLITUS, TYPE 1; FEMALE; LYMPH NODES; MICE; MICE, INBRED NOD; PANCREAS; RECEPTORS, CHEMOKINE; RNA, MESSENGER; SPLEEN; TH1 CELLS;

EID: 31344462462     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2005.09.027     Document Type: Article

References (25)

1. M.A. Atkinson, and G.S. Eisenbarth Type 1 diabetes: new perspectives on disease pathogenesis and treatment Lancet 358 2001 221 229
2. H. Kikutani, and S. Makino The murine autoimmune diabetes model: NOD and related strains Adv Immunol 51 1992 285 322
3. T.L. Delovitch, and B. Singh The nonobese diabetic mouse as a model of autoimmune disease: immune dysregulation gets the NOD Immunity 7 1997 727 738
4. A.D. Luster Chemokine - chemotactic cytokines that mediate inflammation N Engl J Med 338 1998 436 445
5. S. Arimilli, W. Ferlin, N. Solvason, S. Deshpande, M. Howard, and S. Mocci Chemokines in autoimmune diseases Immunol Rev 177 2000 43 51
6. B.T. Fife, K.J. Kennedy, M.C. Paniagua, N.W. Lukacs, S.L. Kunkel, and A.D. Luster CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis J Immunol 166 2001 7617 7624
7. G. Wildbaum, N. Netzer, and N. Karin Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis J Immunol 168 2002 5885 5892
8. S. Narumi, T. Kauraki, H. Yoneyama, H. Iwamura, Y. Kobayashi, and K. Matsushima Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis Eur J Immunol 32 2002 1784 1791
9. I. Salomon, N. Netzer, G. Wildbaum, S. Schif-Zuck, G. Maor, and N. Karin Targeting the function of IFN-gamma-inducible protein-10 suppresses ongoing adjuvant arthritis J Immunol 169 2002 2685 2693
10. A. Shimada, J. Morimoto, K. Kodama, R. Suzuki, Y. Oikawa, and O. Funae Elevated serum IP-10 levels observed in type 1 diabetes Diabetes Care 24 2001 510 515
11. R. Suzuki, A. Shimada, T. Maruyama, O. Funae, J. Morimoto, and K. Kodama T-cell function anti-GAD65+ diabetes with residual beta-cell function J Autoimmun 20 2003 83 90
12. F. Nicoletti, I. Conget, M. Di Mauro, R. Di Marco, M.C. Mazzarino, and K. Bendtzen Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type 1 diabetes mellitus patients and subjects at risk of developing the disease Diabetologia 45 2002 1107 1110
13. J. Morimoto, H. Yoneyama, A. Shimada, T. Shigihara, S. Yamada, and Y. Oikawa CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis J Immunol 173 2004 7017 7024
14. Y. Oikawa, A. Shimada, A. Kasuga, J. Morimoto, T. Osaki, and H. Tahara Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice J Immunol 171 2003 5865 5875
15. U. Christen, D.B. McGavern, A.D. Luster, M.G. von Herrath, and M.B. Oldstone Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa CXC chemokine ligand (CXCL10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease J Immunol 171 2003 6838 6845
16. A.K. Cardozo, P. Proost, C. Gysemans, M.C. Chen, C. Mathieu, and D.L. Eizirik IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice Diabetologia 46 2003 255 266
17. S. Frigerio, T. Junt, B. Lu, C. Gerard, U. Zumsteg, and G.A. Hollander Beta cells are responsible for CXCR3-mediated T cell infiltration in insulitis Nat Med 8 2002 1414 1420
18. A. Shimada, B. Charlton, C. Taylor-Edwards, and C.G. Fathman Beta cell destruction may be a late consequence of the autoimmune process in non-obese diabetic mice Diabetes 45 1996 1063 1067
19. S. Yamada, J. Irie, A. Shimada, K. Kodama, J. Morimoto, and R. Suzuki Assessment of beta cell mass and oxidative peritoneal exudates in murine type 1 diabetes using adoptive transfer system Autoimmunity 36 2002 63 70
20. S. Narumi, Y. Tominaga, M. Tamaru, S. Shimai, H. Okumura, and K. Nishioji Expression of IFN-inducible protein-10 in chronic hepatitis J Immunol 158 1997 5536 5544
21. J.E. Simpson, J. Newcombe, M.L. Cruzner, and M.N. Woodrofe Expression of the interferon-gamma-inducible chemokine IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions Neuropathol Appl Neurobiol 26 2000 133 142
22. G.D. Han, H. Koike, T. Nakatsu, K. Suzuki, H. Yoneyama, and S. Narumi IFN-inducible protein-10 has a differential role in podocyte during Thy 1.1 glomerulonephritis J Am Soc Nephrol 14 2003 3111 3126
23. H. Rothe, A. Hausmann, K. Casteels, H. Okamura, M. Kurimoto, and V. Burkart IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis J Immunol 163 1999 1230 1236
24. P. Höglund, J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes J Exp Med 189 1999 331 339
25. S. Turley, L. Poirot, M. Hattori, C. Benoist, and D. Mathis Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type 1 diabetes model J Exp Med 198 2003 1527 1537